These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Immunodiagnosis of human neurocysticercosis using a synthetic peptide selected by phage-display. Hell RC, Amim P, de Andrade HM, de Avila RA, Felicori L, Oliveira AG, Oliveira CA, Nascimento E, Tavares CA, Granier C, Chávez-Olórtegui C. Clin Immunol; 2009 Apr; 131(1):129-38. PubMed ID: 19186111 [Abstract] [Full Text] [Related]
28. Cross-reactivity of anti-Taenia crassiceps cysticerci immune antibodies with Taenia solium antigens. Espíndola NM, De Gaspari EN, Nakamura PM, Vaz AJ. Vet Parasitol; 2000 May 17; 89(4):321-6. PubMed ID: 10799846 [Abstract] [Full Text] [Related]
29. Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis. Gekeler F, Eichenlaub S, Mendoza EG, Sotelo J, Hoelscher M, Löscher T. Eur J Clin Microbiol Infect Dis; 2002 Mar 17; 21(3):227-9. PubMed ID: 11957028 [Abstract] [Full Text] [Related]
30. Relative seroprevalence of cysticercus antigens and antibodies and antibodies to Taenia ova in a population sample in south India suggests immunity against neurocysticercosis. Jayaraman T, Prabhakaran V, Babu P, Raghava MV, Rajshekhar V, Dorny P, Muliyil J, Oommen A. Trans R Soc Trop Med Hyg; 2011 Mar 17; 105(3):153-9. PubMed ID: 21216417 [Abstract] [Full Text] [Related]
31. Detection of IgG in cerebrospinal fluid for diagnosis of neurocysticercosis: evaluation of saline and SDS extracts from Taenia solium and Taenia crassiceps metacestodes by ELISA and immunoblot assay. Barcelos IS, Mineo JR, de Oliveira Silva DA, Ferreira MS, de Moura LP, Biondi GF, Costa-Cruz JM. Trop Med Int Health; 2001 Mar 17; 6(3):219-26. PubMed ID: 11299039 [Abstract] [Full Text] [Related]
32. Neurocysticercosis: relationship between the developmental stage of metacestode present and the titre of specific IgG in the cerebrospinal fluid. Lopez JA, Garcia E, Cortes IM, Sotelo J, Tato P, Molinari JL. Ann Trop Med Parasitol; 2004 Sep 17; 98(6):569-79. PubMed ID: 15324464 [Abstract] [Full Text] [Related]
35. A recombinant 10-kDa protein of Taenia solium metacestodes specific to active neurocysticercosis. Chung JY, Bahk YY, Huh S, Kang SY, Kong Y, Cho SY. J Infect Dis; 1999 Oct 17; 180(4):1307-15. PubMed ID: 10479162 [Abstract] [Full Text] [Related]
36. IgY antibody and human neurocysticercosis: a novel approach on immunodiagnosis using Taenia crassiceps hydrophobic antigens. Carrara GMP, Silva GB, Faria LS, Nunes DS, Ribeiro VS, Lopes CA, Gonçalves-Pires MDRF, Santos MM, Borges IP, Ferreira-Junior Á, Ávila VMR, Costa-Cruz JM. Parasitology; 2020 Feb 17; 147(2):240-247. PubMed ID: 31603062 [Abstract] [Full Text] [Related]
37. Assessment of antigenic fractions of varying hydrophobicity from Taenia solium metacestodes for the diagnosis of human neurocysticercosis. Machado GA, Santiago FM, Mineo JR, Costa-Cruz JM. Trop Med Int Health; 2007 Nov 17; 12(11):1369-76. PubMed ID: 17949403 [Abstract] [Full Text] [Related]
38. Triplex ELISA for Assessing Durability of Taenia solium Seropositivity after Neurocysticercosis Cure. Tang NL, Nash TE, Corda M, Nutman TB, O'Connell EM. Emerg Infect Dis; 2023 Jul 17; 29(7):1340-1348. PubMed ID: 37347506 [Abstract] [Full Text] [Related]